These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2438972)

  • 1. Interference by naproxen in the urinary 5-hydroxyindoleacetic acid assay is due to a metabolite, desmethylnaproxen.
    Walker PL; Pettit BR; Sandler M
    Ann Clin Biochem; 1987 Mar; 24 ( Pt 2)():177-81. PubMed ID: 2438972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans. Effect of cimetidine.
    Vree TB; Van Den Biggelaar-Martea M; Verwey-Van Wissen CP; Vree ML; Guelen PJ
    Br J Clin Pharmacol; 1993 May; 35(5):467-72. PubMed ID: 8512758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of naproxen and its metabolite O-desmethylnaproxen with their acyl glucuronides in human plasma and urine by means of direct gradient high-performance liquid chromatography.
    Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP
    J Chromatogr; 1992 Jul; 578(2):239-49. PubMed ID: 1400803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous quantitative determination of naproxen, its metabolite 6-O-desmethylnaproxen and their five conjugates in plasma and urine samples by high-performance liquid chromatography on dynamically modified silica.
    Andersen JV; Hansen SH
    J Chromatogr; 1992 Jun; 577(2):325-33. PubMed ID: 1400763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and enantioselective gas chromatographic mass-spectrometric separation of O-desmethylnaproxen, the main metabolite of the drug naproxen, as a new environmental contaminant.
    Selke S; Scheurell M; Shah MR; Hühnerfuss H
    J Chromatogr A; 2010 Jan; 1217(3):419-23. PubMed ID: 20006341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling urinary metabolites of naproxen by liquid chromatography-electrospray mass spectrometry.
    Aresta A; Carbonara T; Palmisano F; Zambonin CG
    J Pharm Biomed Anal; 2006 Jun; 41(4):1312-6. PubMed ID: 16581219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of (R)- and (S)-naproxen and (R)- and (S)-6-O-desmethylnaproxen by high-performance liquid chromatography on a Chiral-AGP column.
    Andersen JV; Hansen SH
    J Chromatogr; 1992 Jun; 577(2):362-5. PubMed ID: 1400768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous separation of naproxen and 6-O-desmethylnaproxen metabolite in saliva samples by liquid chromatography-tandem mass spectrometry: Pharmacokinetic study of naproxen alone and associated with esomeprazole.
    Dionísio TJ; Oliveira GM; Morettin M; Faria FC; Santos CF; Calvo AM
    PLoS One; 2020; 15(8):e0236297. PubMed ID: 32780750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans.
    Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP; Vree JB; Guelen PJ
    Biopharm Drug Dispos; 1993 Aug; 14(6):491-502. PubMed ID: 8218967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial transformation of naproxen by Cunninghamella species.
    Zhong DF; Sun L; Liu L; Huang HH
    Acta Pharmacol Sin; 2003 May; 24(5):442-7. PubMed ID: 12740180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen.
    Bowalgaha K; Elliot DJ; Mackenzie PI; Knights KM; Swedmark S; Miners JO
    Br J Clin Pharmacol; 2005 Oct; 60(4):423-33. PubMed ID: 16187975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naproxen metabolites interfere with certain bilirubin assays: elimination of interference by using a Roche bilirubin assay on the Hitachi 917 analyzer.
    Dasgupta A; Langman LJ; Johnson M; Chow L
    Am J Clin Pathol; 2010 Jun; 133(6):878-83. PubMed ID: 20472845
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Oliveira GM; Dionísio TJ; Siqueira-Sandrin VS; Ferrari LAL; Bolani B; Parisi VA; Polanco NLDH; Colombini-Ishikiriama BL; Faria FAC; Santos CF; Calvo AM
    Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin therapy and the measurement of urinary 5-hydroxyindoleacetic acid.
    O'Leary PC; Edelman J; Riley WJ
    Clin Chim Acta; 1982 Dec; 126(3):323-6. PubMed ID: 6185255
    [No Abstract]   [Full Text] [Related]  

  • 15. Naproxen interferes positively with 5-hydroxyindoleacetate assay.
    Bhagat CI; Dick M
    Clin Chem; 1982 May; 28(5):1240. PubMed ID: 6176370
    [No Abstract]   [Full Text] [Related]  

  • 16. Water stable metal-organic framework packed microcolumn for online sorptive extraction and direct analysis of naproxen and its metabolite from urine sample.
    Hu Y; Song C; Liao J; Huang Z; Li G
    J Chromatogr A; 2013 Jun; 1294():17-24. PubMed ID: 23664353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and identification of 6-desmethylnaproxen sulfate as a new metabolite of naproxen in human plasma.
    Kiang CH; Lee C; Kushinsky S
    Drug Metab Dispos; 1989; 17(1):43-8. PubMed ID: 2566468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing naproxen metabolite interference in total bilirubin assays.
    Saifee NH; Ranjitkar P; Greene DN
    Clin Biochem; 2016 Apr; 49(6):514-517. PubMed ID: 26589001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative gas-liquid chromatographic analysis of naproxen, 6-O-desmethyl-naproxen and their conjugates in urine.
    Wan SH; Matin SB
    J Chromatogr; 1979 Mar; 170(2):473-8. PubMed ID: 546849
    [No Abstract]   [Full Text] [Related]  

  • 20. Coupling of TLC and UV-measurement for quantification of naproxen and its main metabolite in urine.
    Abdel-Moety EM; Al-Obaid AM; Jado AI; Lotfi EA
    Eur J Drug Metab Pharmacokinet; 1988; 13(4):267-71. PubMed ID: 3243322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.